Track the 이지바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Food & Beverage sector, 이지바이오 has recorded 2 reports. Market capitalisation: €207.1bn. The latest transaction was disclosed on 17 March 2026 (Other). Among the most active insiders: 이지바이오. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
이지바이오 is a company specializing in the agro-food sector, listed on the XKRX market. It focuses on the development and distribution of organic products.